3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Specimen Handling
4
Nivolumab
4
avelumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
pembrolizumab
2
talimogene laherparepvec
1
prednylidene
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
decitabine and cedazuridine drug combination
1
aldesleukin
1
Sirolimus
1
Saline Solution
1
Radiosurgery
1
Prednisone
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Axitinib
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
budigalimab
×
30 days
×
Clear all
No trials found.